Legal & General Group PLC Hookipa Pharma Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$1.33 - $2.31 $2,447 - $4,250	-1,840 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$9.16 - $19.51 $3,984 - $8,486	435 Added 30.96%	1,840 $17,000
Q1 2021 May 17, 2021	SELL	$10.64 - $14.7 $1,361 - $1,881	-128 Reduced 8.35%	1,405 $19,000
Q3 2020 Nov 13, 2020	SELL	$8.59 - $11.89 $4,114 - $5,695	-479 Reduced 23.81%	1,533 $15,000
Q2 2020 Aug 14, 2020	BUY	$7.23 - $12.1 $3,470 - $5,808	480 Added 31.33%	2,012 $23,000
Q1 2020 May 14, 2020	SELL	$5.9 - $13.8 $3,162 - $7,396	-536 Reduced 25.92%	1,532 $13,000
Q4 2019 Feb 13, 2020	BUY	$6.51 - $12.23 $13,462 - $25,291	2,068 New	2,068 $25,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.